150 related articles for article (PubMed ID: 6573951)
1. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
3. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
4. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
5. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
[No Abstract] [Full Text] [Related]
6. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
Tsiftsoglou AS; Wong W; Hyman R; Minden M; Robinson SH
Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
[TBL] [Abstract][Full Text] [Related]
7. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
Steinheider G; Westendorf J; Marquardt H
Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
Gamba-Vitalo C; Blair OC; Keyes SR; Sartorelli AC
Cancer Res; 1986 Mar; 46(3):1189-94. PubMed ID: 3455881
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Morin MJ; Sartorelli AC
Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
Marsh JC; Brown BJ; Nierenburg MM
Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
[TBL] [Abstract][Full Text] [Related]
11. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo.
Jing Y; Nakaya K; Han R
Anticancer Res; 1993; 13(4):1049-54. PubMed ID: 8352524
[TBL] [Abstract][Full Text] [Related]
13. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60).
Fibach E; Peled T; Rachmilewitz EA
J Cell Physiol; 1982 Oct; 113(1):152-8. PubMed ID: 6957411
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline-induced inhibition of a calcium action potential in differentiated murine neuroblastoma cells.
Santone KS; Oakes SG; Taylor SR; Powis G
Cancer Res; 1986 Jun; 46(6):2659-64. PubMed ID: 2421881
[TBL] [Abstract][Full Text] [Related]
15. WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
Gamba-Vitalo C; Carman MD; Sartorelli AC
Cancer Commun; 1989; 1(3):157-65. PubMed ID: 2561737
[TBL] [Abstract][Full Text] [Related]
16. Mode of differentiation of human promyelocytic leukemia cell line, HL-60, by 1 alpha,25-dihydroxyvitamin D3.
Matsuhisa T; Mori Y
Blood Cells Mol Dis; 1995; 21(1):42-8. PubMed ID: 7655860
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H
Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
Bhalla K; Hindenburg A; Taub RN; Grant S
Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of HL-60 promyelocytic leukemia cells monitored by flow cytometric measurement of nitro blue tetrazolium (NBT) reduction.
Blair OC; Carbone R; Sartorelli AC
Cytometry; 1985 Jan; 6(1):54-61. PubMed ID: 3855396
[TBL] [Abstract][Full Text] [Related]
20. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
